data_2sxl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2sxl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.456 -0.572 . . . . 3.86 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 65.5 m -150.99 143.46 24.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 2.6 109.445 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.606 ' CB ' ' O ' ' A' ' 2' ' ' SER . 63.0 m-20 136.03 114.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.45 0.643 . . . . 1.66 109.381 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.477 ' O ' ' CD2' ' A' ' 6' ' ' LEU . 9.3 t -121.04 65.62 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 2.54 108.534 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 3.1 t-20 -40.1 137.91 0.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.487 0.66 . . . . 2.28 110.077 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' A' ' 52' ' ' PHE . 19.9 mt -118.35 178.74 4.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.485 -0.759 . . . . 1.1 109.585 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.535 ' HB ' ' CE1' ' A' ' 47' ' ' TYR . 13.7 pt -131.06 124.6 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.988 -0.685 . . . . 1.19 109.201 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 2.6 t -97.51 123.26 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.55 -0.907 . . . . 1.24 108.55 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -111.23 -171.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.919 -1.113 . . . . 1.57 110.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 74' ' ' ARG . 17.3 m-85 64.76 38.33 6.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.676 -0.64 . . . . 2.2 109.568 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 75' ' ' LEU . 11.4 mt -92.83 151.09 40.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 1.12 109.226 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' CG ' ' HB3' ' A' ' 15' ' ' MET . 35.0 Cg_endo -78.2 0.73 9.62 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.499 2.133 . . . . 0.57 110.247 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 75.73 -2.23 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 1.92 109.621 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 p30 -130.48 -11.93 3.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 1.25 109.842 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.521 ' CE ' HD23 ' A' ' 20' ' ' LEU . 5.8 ptm -61.53 173.81 0.88 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.103 -0.998 . . . . 2.42 109.341 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 10.4 p -133.64 144.41 49.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.905 . . . . 1.0 109.939 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 82.0 m-20 -57.33 -15.44 6.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 1.34 108.973 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -58.03 6.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 4.02 108.783 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 16' ' ' THR . 3.0 pt-20 -56.87 -33.6 67.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.261 -1.385 . . . . 1.2 107.261 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' HB3' ' CE2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -62.64 -36.42 82.77 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.115 0.96 . . . . 1.19 108.795 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 4.7 t80 -65.72 -31.05 71.83 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.482 -0.933 . . . . 0.99 108.482 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.07 62.92 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.852 -0.796 . . . . 1.12 108.852 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -98.31 -64.02 1.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.917 0.865 . . . . 1.13 109.607 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 24' ' ' PHE . 2.1 m-30 -57.44 -48.39 79.27 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.014 -0.539 . . . . 2.12 110.777 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 2.0 tmt_? -46.97 -22.65 0.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.075 -1.016 . . . . 3.43 109.429 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.62 -31.18 12.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 1.08 109.205 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 65' ' ' LEU . 9.3 mt -79.6 -66.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 1.34 109.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 52' ' ' PHE . . . -123.97 157.97 18.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.41 109.512 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.42 71.06 6.98 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.743 2.295 . . . . 0.68 110.031 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.557 HD12 ' CB ' ' A' ' 24' ' ' PHE . 44.3 mt -51.3 148.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 1.35 109.947 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 51' ' ' ASP . 47.2 p30 -108.15 -18.52 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 1.53 108.84 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 55.3 m -166.54 146.51 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 1.21 108.948 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' CG2' ' A' ' 30' ' ' ILE . 3.6 m -140.42 114.75 9.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.94 -1.1 . . . . 1.44 109.88 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 15.0 mmm-85 -123.82 167.17 14.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 4.16 109.011 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' HA ' ' CB ' ' A' ' 48' ' ' ALA . 83.5 mt -122.02 141.72 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 1.27 108.646 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.471 ' C ' ' CG ' ' A' ' 37' ' ' ARG . 5.1 mtp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.764 -1.21 . . . . 2.07 110.12 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' C ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -163.21 156.58 19.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.622 -0.881 . . . . 4.5 108.622 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 29.3 t0 -43.66 128.85 5.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 2.49 109.572 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 -1.43 57.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 6.78 109.843 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -99.75 -67.69 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 6.07 109.559 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.77 -14.03 26.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 4.8 109.56 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 38' ' ' ASP . . . 85.94 10.84 74.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 3.83 109.507 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.31 103.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -1.137 . . . . 6.53 109.388 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.474 ' CB ' ' HB3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -86.94 155.66 20.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 2.69 109.492 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.39 2.38 7.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 2.44 110.305 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 47' ' ' TYR . . . 92.75 93.33 1.46 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.204 -1.158 . . . . 1.32 110.204 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' CZ ' ' A' ' 49' ' ' PHE . 16.4 t80 161.03 129.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.642 -0.917 . . . . 2.2 108.911 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 35' ' ' ILE . . . -145.55 -174.93 4.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.064 -1.022 . . . . 1.11 109.982 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CZ ' ' OH ' ' A' ' 47' ' ' TYR . 12.8 m-85 -120.37 124.07 44.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.744 . . . . 2.13 110.684 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG12 ' CD2' ' A' ' 24' ' ' PHE . 52.3 t -132.69 109.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.759 -1.2 . . . . 1.1 107.759 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 5' ' ' ASN . 30.8 t70 -95.44 143.94 26.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.073 -1.017 . . . . 1.12 110.348 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.567 ' O ' ' CG2' ' A' ' 53' ' ' THR . 27.1 m-85 -103.76 -12.02 17.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.464 -0.772 . . . . 2.03 109.203 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.567 ' CG2' ' O ' ' A' ' 52' ' ' PHE . 9.3 t 47.82 23.15 0.42 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.521 -0.737 . . . . 1.15 109.392 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 18.0 m -107.75 -42.99 4.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.679 -1.23 . . . . 1.15 107.679 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 38.3 tt0 61.84 14.55 6.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.666 0.746 . . . . 2.04 109.584 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -148.72 -77.57 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.887 -1.153 . . . . 2.56 107.887 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -56.52 -34.07 66.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.4 -1.333 . . . . 1.35 107.4 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 63.8 p -60.26 -53.54 56.49 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.116 -0.698 . . . . 1.28 109.116 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 2.4 mt-30 -48.26 -43.75 32.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 2.08 109.244 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -46.6 89.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.028 . . . . 3.2 108.275 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 27' ' ' ILE . . . -64.68 -17.61 64.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.933 -0.765 . . . . 1.09 108.933 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.597 HD11 ' CE2' ' A' ' 79' ' ' TYR . 11.0 mt -78.75 -35.1 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.885 -0.783 . . . . 1.15 108.885 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -76.1 -24.31 55.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.381 -0.97 . . . . 3.21 108.381 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 65' ' ' LEU . 93.4 t -92.34 -73.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.46 -0.775 . . . . 1.16 110.068 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.541 ' CD1' HD12 ' A' ' 27' ' ' ILE . 14.6 mt -40.08 -31.66 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.473 -0.767 . . . . 1.24 110.344 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.518 ' CA ' HG11 ' A' ' 77' ' ' VAL . 12.2 t-20 -47.44 102.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.82 109.708 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 75' ' ' LEU . . . 82.44 60.37 2.12 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.845 -1.169 . . . . 0.37 110.708 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' A' ' 75' ' ' LEU . 10.2 pt -92.33 -119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.953 -1.321 . . . . 1.08 108.811 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 73' ' ' LYS . 70.9 m -160.72 120.58 2.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.35 -1.469 . . . . 1.24 110.849 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.584 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 7.5 p -101.61 54.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 2.06 109.797 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 72' ' ' ASN . 5.2 mtm180 52.28 18.71 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 4.82 110.051 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 10.0 t-20 -179.33 -29.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.819 -1.176 . . . . 3.01 110.556 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.5 mmtm -135.21 -154.4 0.58 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.051 -1.031 . . . . 3.0 109.488 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.6 mtt180 -140.51 104.49 4.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.158 -0.964 . . . . 3.58 109.524 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.584 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 3.7 mm? -50.39 169.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.238 -0.914 . . . . 1.48 110.384 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.7 tttm -128.92 161.72 29.22 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.31 -1.367 . . . . 2.47 107.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 77' ' ' VAL . 6.1 p -152.67 117.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 1.11 110.152 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -129.37 170.52 13.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 1.69 109.436 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CE2' HD11 ' A' ' 62' ' ' ILE . 4.4 m-85 -83.35 45.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 2.17 109.829 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' HG22 ' A' ' 7' ' ' ILE . . . 54.41 69.52 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 1.23 110.05 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.599 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -154.26 55.81 1.37 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.942 . . . . 5.05 109.785 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 36.9 Cg_endo -78.56 163.53 26.76 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.609 2.206 . . . . 3.12 110.723 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.86 58.69 6.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.161 -1.176 . . . . 5.3 110.161 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 85' ' ' GLU . . . 59.41 57.47 19.46 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.598 -1.401 . . . . 6.24 109.598 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.5 tm-20 45.35 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -1.152 . . . . 8.59 109.887 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 87' ' ' ILE . 34.4 m 40.99 43.49 1.79 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.314 -0.867 . . . . 5.99 109.884 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.516 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.5 OUTLIER 77.58 141.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 6.73 109.289 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.955 -1.022 . . . . 9.03 109.533 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.456 -0.572 . . . . 3.33 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 65.5 m -150.99 143.46 24.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 2.21 109.445 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.606 ' CB ' ' O ' ' A' ' 2' ' ' SER . 63.0 m-20 136.03 114.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.45 0.643 . . . . 1.56 109.381 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 4' ' ' THR . 9.3 t -121.04 65.62 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 2.12 108.534 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 3.1 t-20 -40.1 137.91 0.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.487 0.66 . . . . 2.19 110.077 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.712 ' CD2' HD11 ' A' ' 62' ' ' ILE . 19.9 mt -118.35 178.74 4.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.485 -0.759 . . . . 0.38 109.585 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.701 HG22 ' CE1' ' A' ' 49' ' ' PHE . 13.7 pt -131.06 124.6 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.988 -0.685 . . . . 0.52 109.201 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 2.6 t -97.51 123.26 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.55 -0.907 . . . . 0.63 108.55 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -111.23 -171.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.919 -1.113 . . . . 1.5 110.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 74' ' ' ARG . 17.3 m-85 64.76 38.33 6.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.676 -0.64 . . . . 1.29 109.568 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.916 HD22 ' SD ' ' A' ' 15' ' ' MET . 11.4 mt -92.83 151.09 40.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.49 109.226 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' CG ' ' HB3' ' A' ' 15' ' ' MET . 35.0 Cg_endo -78.2 0.73 9.62 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.499 2.133 . . . . 0.49 110.247 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 75.73 -2.23 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 1.78 109.621 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' OD1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 p30 -130.48 -11.93 3.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 1.25 109.842 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.916 ' SD ' HD22 ' A' ' 11' ' ' LEU . 5.8 ptm -61.53 173.81 0.88 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.103 -0.998 . . . . 1.81 109.341 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 10.4 p -133.64 144.41 49.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.905 . . . . 0.33 109.939 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 82.0 m-20 -57.33 -15.44 6.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 1.34 108.973 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -58.03 6.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 3.43 108.783 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 16' ' ' THR . 3.0 pt-20 -56.87 -33.6 67.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.261 -1.385 . . . . 1.2 107.261 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.751 HD13 ' CE2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -62.64 -36.42 82.77 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.115 0.96 . . . . 0.37 108.795 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 4.7 t80 -65.72 -31.05 71.83 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.482 -0.933 . . . . 0.41 108.482 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.07 62.92 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.852 -0.796 . . . . 0.36 108.852 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -98.31 -64.02 1.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.917 0.865 . . . . 0.33 109.607 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.756 ' CB ' HD11 ' A' ' 30' ' ' ILE . 2.1 m-30 -57.44 -48.39 79.27 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.014 -0.539 . . . . 1.22 110.777 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 2.0 tmt_? -46.97 -22.65 0.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.075 -1.016 . . . . 2.78 109.429 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.62 -31.18 12.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.32 109.205 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.056 HD13 HD11 ' A' ' 65' ' ' LEU . 9.3 mt -79.6 -66.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.68 109.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' HA3' ' CD1' ' A' ' 52' ' ' PHE . . . -123.97 157.97 18.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.36 109.512 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.42 71.06 6.98 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.743 2.295 . . . . 0.58 110.031 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.999 HG21 ' SG ' ' A' ' 33' ' ' CYS . 44.3 mt -51.3 148.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.73 109.947 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 51' ' ' ASP . 47.2 p30 -108.15 -18.52 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 1.05 108.84 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 55.3 m -166.54 146.51 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.54 108.948 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.999 ' SG ' HG21 ' A' ' 30' ' ' ILE . 3.6 m -140.42 114.75 9.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.94 -1.1 . . . . 0.82 109.88 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 15.0 mmm-85 -123.82 167.17 14.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 3.58 109.011 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 83.5 mt -122.02 141.72 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.66 108.646 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.471 ' C ' ' CG ' ' A' ' 37' ' ' ARG . 5.1 mtp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.764 -1.21 . . . . 1.53 110.12 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' C ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -163.21 156.58 19.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.622 -0.881 . . . . 3.9 108.622 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 29.3 t0 -43.66 128.85 5.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 2.49 109.572 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 -1.43 57.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 6.68 109.843 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -99.75 -67.69 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 5.65 109.559 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.77 -14.03 26.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 4.32 109.56 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 38' ' ' ASP . . . 85.94 10.84 74.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 3.5 109.507 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.31 103.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -1.137 . . . . 6.26 109.388 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -86.94 155.66 20.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 2.24 109.492 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.39 2.38 7.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 1.66 110.305 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 47' ' ' TYR . . . 92.75 93.33 1.46 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.204 -1.158 . . . . 1.32 110.204 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.826 ' H ' HD12 ' A' ' 11' ' ' LEU . 16.4 t80 161.03 129.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.642 -0.917 . . . . 1.3 108.911 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 35' ' ' ILE . . . -145.55 -174.93 4.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.064 -1.022 . . . . 0.62 109.982 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE1' HG22 ' A' ' 7' ' ' ILE . 12.8 m-85 -120.37 124.07 44.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.744 . . . . 1.26 110.684 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.725 HG13 HD13 ' A' ' 30' ' ' ILE . 52.3 t -132.69 109.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.759 -1.2 . . . . 0.25 107.759 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 30' ' ' ILE . 30.8 t70 -95.44 143.94 26.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.073 -1.017 . . . . 1.12 110.348 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.769 ' O ' HG22 ' A' ' 53' ' ' THR . 27.1 m-85 -103.76 -12.02 17.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.464 -0.772 . . . . 1.18 109.203 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 52' ' ' PHE . 9.3 t 47.82 23.15 0.42 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.521 -0.737 . . . . 0.47 109.392 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 18.0 m -107.75 -42.99 4.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.679 -1.23 . . . . 0.56 107.679 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 38.3 tt0 61.84 14.55 6.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.666 0.746 . . . . 2.04 109.584 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -148.72 -77.57 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.887 -1.153 . . . . 1.99 107.887 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -56.52 -34.07 66.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.4 -1.333 . . . . 1.35 107.4 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 63.8 p -60.26 -53.54 56.49 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.116 -0.698 . . . . 1.1 109.116 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.504 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 2.4 mt-30 -48.26 -43.75 32.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 1.36 109.244 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -46.6 89.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.028 . . . . 2.51 108.275 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 27' ' ' ILE . . . -64.68 -17.61 64.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.933 -0.765 . . . . 0.38 108.933 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.712 HD11 ' CD2' ' A' ' 6' ' ' LEU . 11.0 mt -78.75 -35.1 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.885 -0.783 . . . . 0.44 108.885 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -76.1 -24.31 55.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.381 -0.97 . . . . 2.82 108.381 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 65' ' ' LEU . 93.4 t -92.34 -73.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.46 -0.775 . . . . 0.39 110.068 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.056 HD11 HD13 ' A' ' 27' ' ' ILE . 14.6 mt -40.08 -31.66 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.473 -0.767 . . . . 0.63 110.344 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.756 ' CA ' HG12 ' A' ' 77' ' ' VAL . 12.2 t-20 -47.44 102.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.41 109.708 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 75' ' ' LEU . . . 82.44 60.37 2.12 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.845 -1.169 . . . . 0.37 110.708 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 65' ' ' LEU . 10.2 pt -92.33 -119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.953 -1.321 . . . . 0.53 108.811 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' LYS . 70.9 m -160.72 120.58 2.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.35 -1.469 . . . . 0.9 110.849 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 70' ' ' VAL . 7.5 p -101.61 54.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 1.53 109.797 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 72' ' ' ASN . 5.2 mtm180 52.28 18.71 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 4.24 110.051 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 10.0 t-20 -179.33 -29.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.819 -1.176 . . . . 2.86 110.556 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.5 mmtm -135.21 -154.4 0.58 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.051 -1.031 . . . . 2.66 109.488 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.6 mtt180 -140.51 104.49 4.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.158 -0.964 . . . . 3.03 109.524 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.709 ' CD1' HD23 ' A' ' 11' ' ' LEU . 3.7 mm? -50.39 169.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.238 -0.914 . . . . 0.81 110.384 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.7 tttm -128.92 161.72 29.22 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.31 -1.367 . . . . 1.99 107.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.756 HG12 ' CA ' ' A' ' 66' ' ' ASN . 6.1 p -152.67 117.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.49 110.152 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -129.37 170.52 13.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 1.35 109.436 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.645 ' HA ' HD22 ' A' ' 6' ' ' LEU . 4.4 m-85 -83.35 45.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 1.29 109.829 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.491 ' HA ' HG23 ' A' ' 7' ' ' ILE . . . 54.41 69.52 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.94 110.05 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.618 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -154.26 55.81 1.37 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.942 . . . . 4.38 109.785 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 36.9 Cg_endo -78.56 163.53 26.76 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.609 2.206 . . . . 3.12 110.723 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.86 58.69 6.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.161 -1.176 . . . . 5.3 110.161 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . 59.41 57.47 19.46 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.598 -1.401 . . . . 5.78 109.598 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.5 tm-20 45.35 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -1.152 . . . . 8.59 109.887 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.73 ' O ' HG22 ' A' ' 87' ' ' ILE . 34.4 m 40.99 43.49 1.79 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.314 -0.867 . . . . 5.72 109.884 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 86' ' ' SER . 0.5 OUTLIER 77.58 141.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 6.36 109.289 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.603 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.955 -1.022 . . . . 8.78 109.533 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.456 -0.572 . . . . 3.33 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 65.5 m -150.99 143.46 24.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 2.21 109.445 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.606 ' CB ' ' O ' ' A' ' 2' ' ' SER . 63.0 m-20 136.03 114.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.45 0.643 . . . . 1.56 109.381 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.622 ' O ' HG23 ' A' ' 4' ' ' THR . 9.3 t -121.04 65.62 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 2.12 108.534 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 3.1 t-20 -40.1 137.91 0.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.487 0.66 . . . . 2.19 110.077 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.712 ' CD2' HD11 ' A' ' 62' ' ' ILE . 19.9 mt -118.35 178.74 4.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.485 -0.759 . . . . 0.38 109.585 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.701 HG22 ' CE1' ' A' ' 49' ' ' PHE . 13.7 pt -131.06 124.6 56.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.988 -0.685 . . . . 0.52 109.201 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 76' ' ' LYS . 2.6 t -97.51 123.26 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.55 -0.907 . . . . 0.63 108.55 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -111.23 -171.36 1.82 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.919 -1.113 . . . . 1.5 110.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 74' ' ' ARG . 17.3 m-85 64.76 38.33 6.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.676 -0.64 . . . . 1.29 109.568 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.916 HD22 ' SD ' ' A' ' 15' ' ' MET . 11.4 mt -92.83 151.09 40.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.49 109.226 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' CG ' ' HB3' ' A' ' 15' ' ' MET . 35.0 Cg_endo -78.2 0.73 9.62 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.499 2.133 . . . . 0.49 110.247 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER 75.73 -2.23 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 1.78 109.621 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' OD1' ' HG2' ' A' ' 12' ' ' PRO . 40.4 p30 -130.48 -11.93 3.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 1.25 109.842 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.916 ' SD ' HD22 ' A' ' 11' ' ' LEU . 5.8 ptm -61.53 173.81 0.88 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.103 -0.998 . . . . 1.81 109.341 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 10.4 p -133.64 144.41 49.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.905 . . . . 0.33 109.939 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 82.0 m-20 -57.33 -15.44 6.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 1.34 108.973 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -58.03 6.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 3.43 108.783 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 16' ' ' THR . 3.0 pt-20 -56.87 -33.6 67.0 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.261 -1.385 . . . . 1.2 107.261 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.751 HD13 ' CE2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -62.64 -36.42 82.77 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.115 0.96 . . . . 0.37 108.795 178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 4.7 t80 -65.72 -31.05 71.83 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.482 -0.933 . . . . 0.41 108.482 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.07 62.92 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.852 -0.796 . . . . 0.36 108.852 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -98.31 -64.02 1.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.917 0.865 . . . . 0.33 109.607 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.756 ' CB ' HD11 ' A' ' 30' ' ' ILE . 2.1 m-30 -57.44 -48.39 79.27 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.014 -0.539 . . . . 1.22 110.777 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HG3' ' CE2' ' A' ' 21' ' ' TYR . 2.0 tmt_? -46.97 -22.65 0.35 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.075 -1.016 . . . . 2.78 109.429 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.62 -31.18 12.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.32 109.205 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.056 HD13 HD11 ' A' ' 65' ' ' LEU . 9.3 mt -79.6 -66.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.387 -0.821 . . . . 0.68 109.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' HA3' ' CD1' ' A' ' 52' ' ' PHE . . . -123.97 157.97 18.46 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.36 109.512 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.42 71.06 6.98 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.743 2.295 . . . . 0.58 110.031 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.999 HG21 ' SG ' ' A' ' 33' ' ' CYS . 44.3 mt -51.3 148.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.37 -0.831 . . . . 0.73 109.947 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 51' ' ' ASP . 47.2 p30 -108.15 -18.52 13.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 1.05 108.84 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 55.3 m -166.54 146.51 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.54 108.948 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.999 ' SG ' HG21 ' A' ' 30' ' ' ILE . 3.6 m -140.42 114.75 9.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.94 -1.1 . . . . 0.82 109.88 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 15.0 mmm-85 -123.82 167.17 14.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 3.58 109.011 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 83.5 mt -122.02 141.72 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.66 108.646 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.471 ' C ' ' CG ' ' A' ' 37' ' ' ARG . 5.1 mtp -100.56 131.32 46.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.764 -1.21 . . . . 1.53 110.12 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' C ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -163.21 156.58 19.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.622 -0.881 . . . . 3.9 108.622 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 29.3 t0 -43.66 128.85 5.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 2.49 109.572 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 -1.43 57.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 6.68 109.843 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -99.75 -67.69 0.84 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 5.65 109.559 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.77 -14.03 26.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 4.32 109.56 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 38' ' ' ASP . . . 85.94 10.84 74.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 3.5 109.507 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.31 103.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -1.137 . . . . 6.26 109.388 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -86.94 155.66 20.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 2.24 109.492 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.39 2.38 7.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 1.66 110.305 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 47' ' ' TYR . . . 92.75 93.33 1.46 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.204 -1.158 . . . . 1.32 110.204 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.826 ' H ' HD12 ' A' ' 11' ' ' LEU . 16.4 t80 161.03 129.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.642 -0.917 . . . . 1.3 108.911 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 35' ' ' ILE . . . -145.55 -174.93 4.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.064 -1.022 . . . . 0.62 109.982 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE1' HG22 ' A' ' 7' ' ' ILE . 12.8 m-85 -120.37 124.07 44.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.744 . . . . 1.26 110.684 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.725 HG13 HD13 ' A' ' 30' ' ' ILE . 52.3 t -132.69 109.96 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.759 -1.2 . . . . 0.25 107.759 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 30' ' ' ILE . 30.8 t70 -95.44 143.94 26.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.073 -1.017 . . . . 1.12 110.348 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.769 ' O ' HG22 ' A' ' 53' ' ' THR . 27.1 m-85 -103.76 -12.02 17.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.464 -0.772 . . . . 1.18 109.203 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 52' ' ' PHE . 9.3 t 47.82 23.15 0.42 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.521 -0.737 . . . . 0.47 109.392 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 18.0 m -107.75 -42.99 4.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.679 -1.23 . . . . 0.56 107.679 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 38.3 tt0 61.84 14.55 6.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.666 0.746 . . . . 2.04 109.584 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -148.72 -77.57 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.887 -1.153 . . . . 1.99 107.887 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -56.52 -34.07 66.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.4 -1.333 . . . . 1.35 107.4 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.588 ' HB2' ' CD2' ' A' ' 52' ' ' PHE . 63.8 p -60.26 -53.54 56.49 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.116 -0.698 . . . . 1.1 109.116 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.504 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 2.4 mt-30 -48.26 -43.75 32.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 1.36 109.244 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -46.6 89.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.028 . . . . 2.51 108.275 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 27' ' ' ILE . . . -64.68 -17.61 64.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.933 -0.765 . . . . 0.38 108.933 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.712 HD11 ' CD2' ' A' ' 6' ' ' LEU . 11.0 mt -78.75 -35.1 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.885 -0.783 . . . . 0.44 108.885 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -76.1 -24.31 55.0 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.381 -0.97 . . . . 2.82 108.381 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 65' ' ' LEU . 93.4 t -92.34 -73.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.46 -0.775 . . . . 0.39 110.068 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.056 HD11 HD13 ' A' ' 27' ' ' ILE . 14.6 mt -40.08 -31.66 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.473 -0.767 . . . . 0.63 110.344 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.756 ' CA ' HG12 ' A' ' 77' ' ' VAL . 12.2 t-20 -47.44 102.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 1.41 109.708 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 75' ' ' LEU . . . 82.44 60.37 2.12 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.845 -1.169 . . . . 0.37 110.708 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 65' ' ' LEU . 10.2 pt -92.33 -119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.953 -1.321 . . . . 0.53 108.811 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' LYS . 70.9 m -160.72 120.58 2.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.35 -1.469 . . . . 0.9 110.849 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 70' ' ' VAL . 7.5 p -101.61 54.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 1.53 109.797 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 72' ' ' ASN . 5.2 mtm180 52.28 18.71 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 4.24 110.051 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 10.0 t-20 -179.33 -29.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.819 -1.176 . . . . 2.86 110.556 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.5 mmtm -135.21 -154.4 0.58 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.051 -1.031 . . . . 2.66 109.488 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.6 mtt180 -140.51 104.49 4.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.158 -0.964 . . . . 3.03 109.524 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.709 ' CD1' HD23 ' A' ' 11' ' ' LEU . 3.7 mm? -50.39 169.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.238 -0.914 . . . . 0.81 110.384 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.7 tttm -128.92 161.72 29.22 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.31 -1.367 . . . . 1.99 107.31 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.756 HG12 ' CA ' ' A' ' 66' ' ' ASN . 6.1 p -152.67 117.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.49 110.152 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -129.37 170.52 13.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.454 -0.779 . . . . 1.35 109.436 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.645 ' HA ' HD22 ' A' ' 6' ' ' LEU . 4.4 m-85 -83.35 45.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 1.29 109.829 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.491 ' HA ' HG23 ' A' ' 7' ' ' ILE . . . 54.41 69.52 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.94 110.05 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.618 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -154.26 55.81 1.37 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.942 . . . . 4.38 109.785 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 36.9 Cg_endo -78.56 163.53 26.76 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.609 2.206 . . . . 3.12 110.723 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.86 58.69 6.71 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.161 -1.176 . . . . 5.3 110.161 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . 59.41 57.47 19.46 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.598 -1.401 . . . . 5.78 109.598 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' GLY . 3.5 tm-20 45.35 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -1.152 . . . . 8.59 109.887 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.73 ' O ' HG22 ' A' ' 87' ' ' ILE . 34.4 m 40.99 43.49 1.79 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.314 -0.867 . . . . 5.72 109.884 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 86' ' ' SER . 0.5 OUTLIER 77.58 141.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 6.36 109.289 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.603 ' H ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.955 -1.022 . . . . 8.78 109.533 179.728 . . . . . . . . 2 2 . 1 stop_ save_